The discovery of a company specialized in the use of cannabis as a medication might bring about so big a change that it can alter the medical world forever.
Namely, the revolutionary discovery is a pain patch which soothes diabetic nerve pain and symptoms of fibromyalgia.
These adhesive patches are used as transdermal patches, which when stuck to the skin, release potent chemicals which alleviate neurological nerve pain due to diabetes and fibromyalgia. The controlled dose of this medication can be administered daily and causes no side-effects.
The company which designed these pain patches, Cannabis Science, claims:
“Promote healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive which will be containing high potency cannabinoid (CBD) extract that slowly enters the bloodstream and then penetrates the central nervous system of the patient delivering the pain relief sought.”
The main cannabinoid in cannabis is THC, while CBD is the second one. It soothes pain and inflammation and leads to only a few side effects, such as the hallucinogenic effects commonly linked to THC.
According to Mr. Raymond C Dabney, CEO of Cannabis Science:
“The development of these two new pharmaceutical medicinal applications is just the tip of the iceberg for what we see as the future for Cannabis Science. While we strive to increase our land capacity for growth and facilities to produce our own product to supply our scientists with proprietary materials to make these formulations, we are also busy researching more potential needs for Cannabis related medical applications and developing the methods for delivery of these medications.”
Even 10% of all of us suffer from fibromyalgia, and many people are not yet diagnosed. Since nerve neuropathy diabetic pain affects numerous people all over the world, this medication might be a huge success in the treatment of its symptoms, and even curing the illnesses completely.
The conclusion of Mr. Dabney is as follows:
“As more states nationwide legislate for the legalization of cannabis and cannabis-derived medications, we here at Cannabis Science are focused on developing pharmaceutical formulations and applications to supply the huge growing demand expected over the coming few years.”